Observe Medical Asa (OBSRV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Observe Medical Asa (OBSRV) has a cash flow conversion efficiency ratio of -0.829x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-24.83 Million ≈ $-2.61 Million USD) by net assets (Nkr29.96 Million ≈ $3.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OBSRV cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Observe Medical Asa - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Observe Medical Asa's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Observe Medical Asa Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Observe Medical Asa ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Diamyd Medical AB (publ)
ST:DMYD-B
|
-0.233x |
|
Hindprakash Industries Limited
NSE:HPIL
|
0.004x |
|
Theta Edge Bhd
KLSE:9075
|
-0.100x |
|
Dadi Early-Childhood Education Group Ltd
TWO:8437
|
-0.001x |
|
Immo Mcc NV
BR:MCC
|
N/A |
|
Barnwell Industries Inc
NYSE MKT:BRN
|
-0.216x |
|
Georgia Capital PLC
LSE:CGEO
|
-0.001x |
|
Unimit Engineering Public Company Limited
BK:UEC
|
0.018x |
Annual Cash Flow Conversion Efficiency for Observe Medical Asa (2016–2025)
The table below shows the annual cash flow conversion efficiency of Observe Medical Asa from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see OBSRV stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr29.96 Million ≈ $3.15 Million |
Nkr-24.83 Million ≈ $-2.61 Million |
-0.829x | +34.86% |
| 2024-12-31 | Nkr24.11 Million ≈ $2.54 Million |
Nkr-30.68 Million ≈ $-3.23 Million |
-1.273x | -483.24% |
| 2023-12-31 | Nkr112.08 Million ≈ $11.79 Million |
Nkr-24.45 Million ≈ $-2.57 Million |
-0.218x | +41.25% |
| 2022-12-31 | Nkr138.31 Million ≈ $14.55 Million |
Nkr-51.37 Million ≈ $-5.41 Million |
-0.371x | -123.71% |
| 2021-12-31 | Nkr-14.12 Million ≈ $-1.49 Million |
Nkr-22.13 Million ≈ $-2.33 Million |
1.567x | +247.31% |
| 2020-12-31 | Nkr20.35 Million ≈ $2.14 Million |
Nkr-21.64 Million ≈ $-2.28 Million |
-1.064x | -10.69% |
| 2019-12-31 | Nkr14.54 Million ≈ $1.53 Million |
Nkr-13.97 Million ≈ $-1.47 Million |
-0.961x | -93.26% |
| 2018-12-31 | Nkr16.82 Million ≈ $1.77 Million |
Nkr-8.36 Million ≈ $-880.11K |
-0.497x | +42.36% |
| 2017-12-31 | Nkr11.39 Million ≈ $1.20 Million |
Nkr-9.83 Million ≈ $-1.03 Million |
-0.863x | -21.31% |
| 2016-12-31 | Nkr14.70 Million ≈ $1.55 Million |
Nkr-10.45 Million ≈ $-1.10 Million |
-0.711x | -- |
About Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a dig… Read more